lumbar
-
Spine
ChoiceSpine™ Announces Line Extension of their Harrier™ Stand-Alone Anterior Lumbar Interbody Fusion System
November 22, 2022 KNOXVILLE, Tenn.–(BUSINESS WIRE)–ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, announces the launch of…
Read More » -
Spine
Spinal Stabilization Technologies Ltd. Announces Start of LOPAIN 2 Clinical Trial in South America for Lumbar Degenerative Disc Disease
KILKENNY, Ireland, Nov. 16, 2022 /OrthoSpineNews/ — Spinal Stabilization Technologies (SST) has announced the start of the LOPAIN2 clinical trial of the PerQdisc™…
Read More » -
Spine
DiscGenics to Present at 2022 Cell & Gene Meeting on the Mesa
SALT LAKE CITY, Oct. 5, 2022 /PRNewswire/ — DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate…
Read More » -
Spine
Wenzel Spine Announces the Launch of the S-LIF Procedure: Prioritizing Surgical Minimalism for Outpatient Spine Fusion
August 29, 2022 AUSTIN, Texas–(OrthoSpineNews)–Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive surgical and diagnostic solutions…
Read More » -
Spine
Nexus Spine Announces Full Commercial Launch of PressON™ Posterior Lumbar Fixation System
Unique elastic interference technology solves set screw loosening and eliminates rod bending August 23, 2022 SALT LAKE CITY–(BUSINESS WIRE)–Nexus Spine,…
Read More » -
Spine
AxioMed LLC Submits Final Module III to the FDA Becoming the First and Only Lumbar Viscoelastic Total Disc Replacement Company to Complete a USA IDE Clinical Trial
On August 8, 2022, AxioMed LLC submitted to the FDA all the required documents for Module III. This is the…
Read More » -
Spine
SeaSpine® Announces Full Commercial Launch of Meridian™ Anterior Lumbar Interbody System Featuring Reef ™ A Interbody
CARLSBAD, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Biologics
BioRestorative Therapies Announces First Patient Enrolled for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
First Patient Enrollment Milestone Completed MELVILLE, NY., June 30, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:…
Read More » -
Biologics
BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
MELVILLE, NY., June 22, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused…
Read More » -
Biologics
BioRestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
— First Site Will Enroll First Patient in the Clinical Study– MELVILLE, NY., June 13, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies,…
Read More » -
Spine
Zavation Medical Products, LLC, receives FDA 510K Clearance for eZspand™ Lateral Cage as an addition to its eZspand™ Interbody System.
FLOWOOD, Miss., June 10, 2022 /PRNewswire/ — Zavation Medical Products (“Zavation” or the “Company”), an innovative designer and manufacturer of high-quality spinal…
Read More » -
Spine
Accelus Launches TiHawk7™ Titanium-Bonded Multidirectionally Expanding Interbody Cage to Support Endoscopic and MIS Lumbar Fusion Procedures
TiHawk7 combines ultra-low 7mm insertion profile with strong titanium/PEEK adhesion while still allowing for radiographic verification of fusion PALM BEACH…
Read More » -
Spine
ChoiceSpine™ Announces Full Market Release of Next Generation Harrier™ Stand-Alone Anterior Lumbar Interbody Fusion System
April 19, 2022 KNOXVILLE, Tenn.–(BUSINESS WIRE)–ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, announces today that it…
Read More » -
Regulatory
AxioMed Announces Progress with Completing Module I-III Lumbar FDA Submission of The First Lumbar Viscoelastic Disc Replacement to Complete a US IDE Clinical Study
AxioMed presses forward on its FDA submission of documents needed to complete the last Module III of its FDA application…
Read More » -
Spine
Major Commercial Third Party Payer in Utah and Idaho Significantly Expands Patient Access to Centinel Spine’s prodisc® L for One- and Two-level Lumbar Total Disc Replacement
– A major commercial third party payer in Utah and Idaho, representing 837,000 covered lives, has established positive coverage for both one- and…
Read More »